The U.S. government drifted further into red ink during May, with a burgeoning debt and deficit issue getting worse.

Officials at the FDA say they want to speed up approvals for new drugs and devices using tech like the new "Elsa" AI system. More news is on other uses of AI in health care, Eli Lilly refusing to work ...

The portfolio continues to invest in companies we believe are strong and improving and have improvement that is sustainable.

Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...

Private equity firms have poured billions into healthcare in recent years. Psychiatric hospitals are an increasingly ...

Recognition Follows Claimable's Launch of GLP-1 Support, Helping Patients Navigate One of the Most Denied Treatments in the U ...

Omada Health closed 21% higher in its Nasdaq debut after raising $150 million. Backed by strong growth and GLP-1 momentum, ...

Will Trump's move raise prices of drugs around the world? Read more at straitstimes.com. Read more at straitstimes.com.

The European Medicines Agency’s safety committee said on Friday Novo Nordisk’s popular weight-loss and diabetes drugs Wegovy ...

Despite the price drops, the drugs remain costly. Novo Nordisk cut the price of Wegovy by 23 percent for cash payments from $650 to $499 for uninsured patients or people without coverage. The drug’s ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...